City of London Investment Group appoint highly experienced Tazim Essani to the board

City of London Investment Trust

City of London Investment Group plc (LON:CLIG) has announced that Tazim Essani will be joining the Board as a Non-Executive Director (NED) as of 1 February 2021.  Tazim has over 30 years of experience in executive roles at Close Brothers Group plc, Santander UK plc and GE Capital. Tazim has a significant track record in strategy and M&A in financial services in the UK and internationally covering integration, management transition and realization of synergy benefits.

There is no further information required to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules.

Barry Aling, Chairman of City of London Investment Group, said: “On behalf of the Board I would like to give a warm welcome to Tazim Essani as our new NED. Tazim’s extensive experience of driving change and delivering significant results across a range of businesses will add an important dimension to the Board’s skill set and we look forward to her contribution as we seek to build on the gains made over the last year.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Ilika plc Advances Solid-State Batteries With 10Ah Goliath Breakthrough (Video)

Ilika plc has shipped its 10Ah Goliath solid-state battery prototypes, marking a major scale-up from earlier designs. CEO Graeme Purdy outlines how higher-energy materials and an automated pilot line delivered a 93% yield, signalling readiness for larger-scale manufacturing.

Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production

Harbour Energy has agreed to acquire most subsidiaries of Waldorf Energy Partners and Waldorf Production for $170 million, a move expected to add 20 kboepd of oil weighted production and 35 mmboe of 2P reserves.

TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs

TwentyFour Income Fund noted improved market sentiment in November, supported by progress in Ukraine peace discussions and a stable UK Budget response.

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026.

UK equities regain investor interest as valuation opportunities widen

Fidelity Special Values manager Alex Wright says UK equities have seen renewed interest as valuations remain attractive compared with global peers. The trust continues to follow a contrarian approach, focusing on undervalued mid and small cap companies and aiming to identify positive change not yet reflected in share prices.

Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT)

As at the end of October 2025, Global Opportunities Trust continued to apply its value focused strategy across global markets, holding a blend of equities, private market investments and significant liquidity positions.

    Search

    Search